Latest Percutaneous coronary intervention Stories
Enrollment in the Phase 3 REGULATE-PCI Trial is Ongoing for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention BASKING RIDGE, N.J., March 10, 2014 /PRNewswire/
Increasing Presence of Domestic Competitors Will Undercut Prices Set by Multinational Companies, According to Findings from Decision Resources Group BURLINGTON, Mass., March 6, 2014
BASKING RIDGE, N.J., March 6, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
REG2 Extends Regado's Next-Generation Anticoagulation Therapy Franchise as Phase 3 REGULATE-PCI Clinical Trial of REG1 Advances BASKING RIDGE, N.J., Feb.
New Patent Extends Coverage to Peptide- and Protein-Based Control Agents BASKING RIDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
BASKING RIDGE, N.J., Feb. 4, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
BASKING RIDGE, N.J., Jan. 31, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
Additional Findings from RADAR Trial Published in Journal of Invasive Cardiology BASKING RIDGE, N.J., Jan. 29, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
FARMINGTON, Mich., Jan. 16, 2014 /PRNewswire/ -- /Continental Who's Who/ -- Dr.
A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...